Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

23 Oct 2025 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed a press release titled ‘Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40mg/20 mL (2 mg/mL), 150mg/30mL (5 mg/mL), and 200mg/20 mL (10 mg/mL) Single-Dose Vials’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..